Bill Clinton on Jeffrey Epstein: ‘I saw nothing, and I did nothing wrong’
The House Oversight forced Bill and Hillary Clinton to testify about Jeffrey Epstein. It has not called for testimony from President Donald Trump.
CoreWeave CEO defends spending plans, tries to combat debt narrative as stock plummets nearly 20%
Coreweave CEO Mike Intrator defended the company’s debt narrative during an interview with CNBC’s “Squawk on the Street” on Friday.
Rubio to travel to Israel to discuss Iran, other issues, State Dept. says
The United States has been pressuring Iran to curb its nuclear program, but talks between the two countries have not led to a breakthrough so far.
Epstein files: Rep. Mace says she’ll call Trump Commerce chief Lutnick to testify
Rep. Nancy Mace’s comments came before the House Oversight Committe was to question ex-President Bill Clinton about his connections to Jeffrey Epstein.
A Palantir options trade to play a potential buying opportunity while defining risk
Jeff Kilburg on how he’s trading Palantir.
Dell shares climb 19% on earnings beat as company navigates rising memory costs
Dell’s strong fourth-quarter results show the company is navigating the memory shortage well so far.
Trump angering MAHA with glyphosate order gives Democrats an opening
Democrats once counted many of the health-conscious followers of Robert F. Kennedy Jr. among their own ranks.
Apple appears to be sitting out the AI arms race. Will the strategy work?
In fiscal 2025, Apple allocated $12.72 billion on capital expenditures likely tied to AI. That’s far less than others.
UBS downgrades the U.S. stock market. Here’s what has the investment bank worried
UBS downgraded U.S. equities to benchmark in a fully invested global equity portfolio, saying factors that powered years of outperformance are starting to fade.
Jim Cramer’s top 10 things to watch in the stock market Friday
Dell reported a true blowout quarter thanks to the AI buildout, and CoreWeave is understandably spending a fortune on capex.